HIMS logo

Hims & Hers Health, Inc. Stock Price

NYSE:HIMS Community·US$12.2b Market Cap
  • 5 Narratives written by author
  • 10 Comments on narratives written by author
  • 813 Fair Values set on narratives written by author

HIMS Share Price Performance

US$53.95
33.45 (163.17%)
37.3% undervalued intrinsic discount
US$86.09
Fair Value
US$53.95
33.45 (163.17%)
37.3% undervalued intrinsic discount
US$86.09
Fair Value
Price US$53.95
BlackGoat US$86.09
AnalystHighTarget US$85.00
AnalystConsensusTarget US$47.42

HIMS Community Narratives

BlackGoat·
Fair Value US$86.09 37.3% undervalued intrinsic discount

Hims: The Platform Powering Personalised Healthcare

29users have liked this narrative
9users have commented on this narrative
137users have followed this narrative
AnalystHighTarget·
Fair Value US$82.55 34.6% undervalued intrinsic discount

Telemedicine And AI Integration Will Redefine Digital Healthcare

0users have liked this narrative
0users have commented on this narrative
15users have followed this narrative
AnalystConsensusTarget·
Fair Value US$47.42 13.8% overvalued intrinsic discount

Telehealth And Hormonal Health Will Transform Global Markets

12users have liked this narrative
0users have commented on this narrative
210users have followed this narrative

HIMS Community Fair Values

Recent HIMS News & Updates

Hims & Hers Health, Inc.'s (NYSE:HIMS) P/S Is Still On The Mark Following 33% Share Price Bounce

Sep 27
Hims & Hers Health, Inc.'s (NYSE:HIMS) P/S Is Still On The Mark Following 33% Share Price Bounce

Hims & Hers Health, Inc. Key Details

US$2.0b

Revenue

US$479.2m

Cost of Revenue

US$1.5b

Gross Profit

US$1.3b

Other Expenses

US$193.6m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
Earnings per share (EPS)
0.86
Gross Margin
76.20%
Net Profit Margin
9.62%
Debt/Equity Ratio
172.3%

Hims & Hers Health, Inc. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

Snowflake Analysis

Excellent balance sheet with reasonable growth potential.

3 Risks
3 Rewards

About HIMS

Founded
n/a
Employees
1637
CEO
Andrew Dudum
WebsiteView website
www.hims.com

Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company’s curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

Market Insight

Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading

U.S. Market Performance

  • 7 Days: -2.7%
  • 3 Months: 5.1%
  • 1 Year: 13.4%
  • Year to Date: 11.7%
Over the last 7 days, the market has dropped 2.7%, driven by a decline of 2.5% in the Information Technology sector. In the last year, the market is actually up 13%. Earnings are forecast to grow by 15% annually. Market details ›